Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Linaclotide Utilisation Study in Selected European Populations Dr Javier Cid 11/03/2020
Finalised Assessment of Utilisation of Pioglitazone in Denmark Post Label Change (July 2011) Dr Javier Cid 11/07/2017
Finalised Post-discharge Clinical and Economic Outcomes Among Patients with ACS Managed with PCI and treated with Prasugrel versus Ticagrelor Dr Cliff Molife 15/06/2015
Ongoing Linaclotide Safety Study for the Assessment of Diarrhoea—Complications and Associated Risk Factors in Selected European Populations with IBS-C Dr Javier Cid 08/12/2020
Ongoing Venous Thromboembolism Treatment Dr Jenkins Aaron 12/06/2020
Ongoing Safety and Incidence of Side Effects in a Cohort of Postmenopausal Women Prescribed Ospemifene Relative to Patients Diagnosed with but not Treated for Vulvar and Vaginal Atrophy (VVA) and Patients on Selective Oestrogen Receptor Modulators (SERMs) for Oestrogen-deficiency Conditions or Breast Cancer Prevention – A Post-Authorisation Safety Study Dr Beth Nordstrom 12/10/2018
Ongoing United States Post-Marketing Observational Cardiovascular Safety Study in Patients taking Naloxegol Dr Eric Wittbrodt 11/10/2018
Ongoing An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Among Patients Aged 18 Years and Older Diagnosed with Non Cancer Pain and Treated with Opioids Chronically Dr Javier Cid 14/02/2017
Ongoing An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Drug Utilization in Selected European Populations Dr Javier Cid 14/02/2017
Ongoing The Comparative Safety and Effectiveness of Warfarin and Dabigatran Utilized in the Department of Defense (DoD) Non-Valvular Atrial Fibrillation (NVAF) Patient Population-A Retrospective Database Analysis Mr Evidera Evidera 20/05/2015